Clinical Trial Update: JSKN003 Versus Physician Choiced Treatment in Patients With HER2-positive and Advanced Colorectal Cancer Who Had Failed to Respond to Oxaliplatin, 5-Fu, and Irinotecan [Phase 3]

View source ↗

Summary

Phase 3 study comparing JSKN003 to physician's choice in HER2-positive advanced colorectal cancer after failure of oxaliplatin, 5-FU, and irinotecan; the trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• JSKN003

Snippet

Sponsor: Shanghai JMT-Bio Inc. | Conditions: HER2-positive Colorectal Cancer | Phase 3 | Status: NOT_YET_RECRUITING